Filing Details
- Accession Number:
- 0001562180-25-004834
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-16 08:48:55
- Reporting Period:
- 2025-06-12
- Filing Date:
- 2025-06-16
- Accepted Time:
- 2025-06-16 08:48:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231589 | A Paul Mahon | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Evp & General Counsel | No | No | No | No |
Transaction Summary
| Sold: | 11,000 shares | Avg. Price: $279.96 | Total Value: $3,079,514.30 |
| Number of Shares After Transactions: | 36,781 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-12 | 11,000 | $135.42 | 47,781 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-12 | 506 | $275.98 | 47,275 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-12 | 1,100 | $276.95 | 46,175 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-12 | 1,837 | $278.41 | 44,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-12 | 1,425 | $279.51 | 42,913 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-12 | 1,375 | $280.70 | 41,538 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-12 | 4,557 | $281.56 | 36,981 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-12 | 200 | $282.27 | 36,781 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-06-12 | 11,000 | $0.00 | 11,000 | $135.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 132,000 | 2023-03-15 | 2027-03-15 | No | 4 | M | Direct |
Footnotes
- This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.
- This transaction was executed in multiple trades at prices ranging from $275.52 to $276.375. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $276.62 to $277.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $278.05 to $279.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $279.06 to $280.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $280.07 USD to $281.04 USD; the price reported above reflects the weighted average sale price.
- This transaction was executed in multiple trades at prices ranging from $281.14 to $282.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $282.25 to $282.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder ofthe issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
